Verified ProfileEN

Anhui Gusuyuan Pharmaceutical Co., Ltd.

Order verification — $199

Manufacturing · Chemical Drug Preparation Manufacturing

Verification dossier

Anhui Gusuyuan Pharmaceutical Co., Ltd. is a Chinese company based in Fuyang, Anhui. The company operates in the chemical drug preparation manufacturing sector, within the broader manufacturing industry. Established 2023, the company has been operating for 3 years.

Sinolinks tracks Anhui Gusuyuan Pharmaceutical Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed items: Drug production; Drug retail; Third-class medical device leasing; Third-class medical device production; Second-class medical device production; Food production; Food sales; Disinfection equipment production; Tea product production; Health food production; Infant formula production; Food for special medical purposes production. General items: First-class medical device sales; Second-class medical device sales; First-class medical device leasing; First-class medical device production; Sales of pre-packaged foods; Sales of pre-packaged health foods; Sales of food for special medical purposes; Sales of infant formula and other infant formula.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review